Target Validation Information | |||||
---|---|---|---|---|---|
Target ID | T37539 | ||||
Target Name | B-cell receptor CD22 | ||||
Target Type | Successful |
||||
Drug Potency against Target | Epratuzumab | Drug Info | Ki = 10 nM | [553078] | |
References | |||||
Ref 553078 | Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(6):R204. doi: 10.1186/ar3179. Epub 2010 Nov 4. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.